Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free KYTX Stock Alerts

Kyverna Therapeutics (KYTX) Institutional Ownership

Kyverna Therapeutics logo
$6.84 +0.02 (+0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$6.84 0.00 (-0.07%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)

Current
Institutional Ownership
Percentage
18.08%
Number of
Institutional Buyers
(last 12 months)
69
Total
Institutional Inflows
(last 12 months)
$157.02M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$9.83M
Get KYTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026WINTON GROUP Ltd17,400$155K0.0%N/A0.028%
9/9/2026IFP Advisors Inc12,500$111K0.0%N/A0.020%
9/9/2026Squarepoint Ops LLC82,867$738K0.0%-43.6%0.134%
9/8/2026Spark Investment Management LLC25,100$224K0.4%N/A0.041%
9/2/2026Allianz Asset Management GmbH11,000$98K0.0%N/A0.018%
8/20/2026Susquehanna Fundamental Investments LLC45,360$404K0.0%N/A0.073%
8/19/2026Wellington Management Group LLP117,442$1.05M0.0%N/A0.190%
8/17/2026Bank of America Corp DE265,405$2.37M0.0%N/A0.429%
8/15/2026Man Group plc68,640$612K0.0%N/A0.111%
8/14/2026Canada Pension Plan Investment Board40,000$356K0.0%N/A0.065%
8/14/2026Legal & General Group Plc4,072$36K0.0%N/A0.007%
8/14/2026The Manufacturers Life Insurance Company82,207$732K0.0%N/A0.133%
8/12/2026Quantbot Technologies LP21,287$190K0.0%N/A0.035%
8/7/2026BlackRock Inc.3,134,807$27.93M0.0%N/A5.157%
8/7/2026Deutsche Bank AG44,853$400K0.0%N/A0.074%
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.25,741$229K0.0%N/A0.042%
8/7/2026AIGH Capital Management LLC2,795,797$24.91M1.6%N/A4.599%
8/6/2026Bank of New York Mellon Corp100,281$894K0.0%N/A0.165%
8/6/2026State of Wyoming10,849$97K0.0%N/A0.018%
8/3/2026Walleye Capital LLC245,587$2.19M0.0%N/A0.404%
5/19/2026Bank of America Corp DE55,728$481K0.0%+94.1%0.092%
5/18/2026ADAR1 Capital Management LLC22,428$194K0.0%-60.9%0.037%
5/15/2026OMERS ADMINISTRATION Corp14,800$128K0.0%-57.5%0.024%
5/14/2026Renaissance Technologies LLC367,492$3.17M0.0%+106.6%0.605%
5/14/2026Walleye Capital LLC38,196$330K0.0%N/A0.063%
5/6/2026Kera Capital Partners Inc.108,083$933K0.1%-18.5%0.179%
4/30/2026AIGH Capital Management LLC2,000,000$17.26M2.4%+33.3%3.304%
4/27/2026Simplify Asset Management Inc.173,106$1.49M0.0%-10.0%0.286%
4/27/2026Y Intercept Hong Kong Ltd114,841$991K0.0%N/A0.190%
4/21/2026Wesbanco Bank Inc.110,300$952K0.0%N/A0.182%
4/21/2026Grey Ledge Advisors LLC10,000$86K0.0%N/A0.017%
4/20/2026Banque Cantonale Vaudoise30,532$263K0.0%N/A0.050%
2/23/2026Kera Capital Partners Inc.132,603$1.25M0.2%-68.6%0.303%
2/18/2026Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/18/2026XTX Topco Ltd23,282$219K0.0%-52.6%0.053%
2/18/2026Quadrature Capital Ltd57,369$539K0.0%N/A0.131%
2/18/2026Millennium Management LLC593,369$5.58M0.0%+7.6%1.355%
2/18/2026Balyasny Asset Management L.P.980,869$9.22M0.0%N/A2.239%
2/18/2026683 Capital Management LLC114,900$1.08M0.0%N/A0.262%
2/18/2026ACT Capital Management LLC25,100$236K0.2%N/A0.057%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/17/2026ADAR1 Capital Management LLC57,428$540K0.0%N/A0.131%
2/17/2026Schonfeld Strategic Advisors LLC28,872$271K0.0%N/A0.066%
2/17/2026Burkehill Global Management LP200,000$1.88M0.1%N/A0.457%
2/17/2026Bain Capital Life Sciences Investors LLC3,110,000$29.23M2.2%-7.7%7.100%
2/17/2026Jump Financial LLC80,299$755K0.0%N/A0.183%
2/17/2026Heights Capital Management Inc.271,822$2.56M0.9%N/A0.621%
2/17/2026Price T Rowe Associates Inc. MD1,762,617$16.57M0.0%+16.6%4.024%
2/17/2026Adage Capital Partners GP L.L.C.1,666,666$15.67M0.0%N/A3.805%
2/16/2026OMERS ADMINISTRATION Corp34,800$327K0.0%N/A0.079%
2/16/2026Squarepoint Ops LLC138,868$1.31M0.0%N/A0.317%
2/16/2026Maven Securities LTD146,400$1.38M0.0%N/A0.334%
2/16/2026Barclays PLC164,668$1.55M0.0%+116.1%0.376%
2/13/2026Marshall Wace LLP135,600$1.28M0.0%N/A0.310%
2/13/2026The Manufacturers Life Insurance Company 134,530$1.26M0.0%+29.6%0.307%
2/13/2026Stifel Financial Corp125,790$1.18M0.0%+224.0%0.287%
2/13/2026Hudson Bay Capital Management LP88,553$832K0.0%N/A0.202%
2/13/2026Alyeska Investment Group L.P.600,000$5.64M0.0%N/A1.370%
2/13/2026Wells Fargo & Company MN74,949$705K0.0%+310.0%0.171%
2/12/2026Renaissance Technologies LLC177,899$1.67M0.0%+8.1%0.406%
2/12/2026Dimensional Fund Advisors LP78,413$737K0.0%N/A0.179%
2/12/2026EntryPoint Capital LLC10,048$94K0.0%N/A0.023%
2/12/2026Federated Hermes Inc.20,705$195K0.0%+36.6%0.047%
2/12/2026Monashee Investment Management LLC195,000$1.83M1.0%N/A0.445%
2/11/2026Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/11/2026Propel Bio Management LLC666,666$6.27M5.4%N/A1.522%
2/10/2026TD Asset Management Inc222,796$2.09M0.0%+35.2%0.509%
2/10/2026Goldman Sachs Group Inc.133,530$1.26M0.0%+209.6%0.305%
2/9/2026Geode Capital Management LLC266,402$2.51M0.0%-4.3%0.608%
2/9/2026Simplify Asset Management Inc.192,339$1.81M0.0%N/A0.439%
2/9/2026Jefferies Financial Group Inc.32,001$301K0.0%+96.3%0.073%
2/6/2026Nano Cap New Millennium Growth Fund L P53,500$503K0.4%N/A0.122%
2/3/2026RFG Advisory LLC445,200$4.19M0.1%N/A1.017%
2/2/2026AIGH Capital Management LLC1,500,000$14.10M3.4%N/A3.425%
1/28/2026Peapod Lane Capital LLC183,820$1.73M1.5%-42.3%0.420%
1/22/2026Phoenix Wealth Advisors12,300$116K0.0%+17.1%0.028%
1/1/2026JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%
11/17/2025Jacobs Levy Equity Management Inc.147,712$886K0.0%N/A0.337%
11/17/2025Woodline Partners LP252,212$1.51M0.0%N/A0.576%
11/17/2025Qube Research & Technologies Ltd36,691$220K0.0%+161.1%0.084%
11/17/2025Prelude Capital Management LLC19,438$117K0.0%-46.4%0.044%
11/17/2025Public Employees Retirement System of Ohio4,600$28K0.0%N/A0.011%
11/17/2025Millennium Management LLC551,635$3.31M0.0%+21.9%1.259%
11/17/2025Bank of America Corp DE64,964$390K0.0%+92.5%0.148%
11/17/2025Ameriprise Financial Inc.12,882$77K0.0%N/A0.029%
11/14/2025Two Sigma Investments LP132,451$795K0.0%+9.8%0.306%
11/14/2025Bridgeway Capital Management LLC174,900$1.05M0.0%+178.1%0.404%
11/13/2025UBS Group AG157,422$945K0.0%+60.4%0.364%
11/13/2025BNP Paribas Financial Markets34,022$204K0.0%+667.8%0.079%
11/13/2025Franklin Resources Inc.677,587$4.07M0.0%-2.5%1.567%
11/13/2025Jefferies Financial Group Inc.16,300$98K0.0%N/A0.038%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
11/10/2025TD Asset Management Inc164,796$989K0.0%-34.7%0.381%
11/10/2025Peapod Lane Capital LLC318,760$1.91M1.7%-19.7%0.737%
11/7/2025Vanguard Group Inc.1,322,625$7.94M0.0%+0.8%3.058%
11/7/2025JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%
11/3/2025Federated Hermes Inc.15,158$91K0.0%-65.6%0.035%
10/21/2025Capital Advisors Inc. OK10,000$60K0.0%N/A0.023%
10/17/2025Ethic Inc.15,353$92K0.0%-9.9%0.035%
8/15/2025Bridgeway Capital Management LLC62,900$193K0.0%-53.9%0.145%
8/15/2025Bank of America Corp DE33,756$104K0.0%+94.8%0.078%
8/14/2025Jane Street Group LLC87,769$269K0.0%N/A0.203%


KYTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 104 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($29.23M), BlackRock Inc. ($27.93M), AIGH Capital Management LLC ($24.91M), Price T Rowe Associates Inc. MD ($16.57M), Adage Capital Partners GP L.L.C. ($15.67M), Gilead Sciences Inc. ($15.43M), and Balyasny Asset Management L.P. ($9.22M).Learn more on Kyverna Therapeutics' institutional investors.

18.08% of Kyverna Therapeutics' stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings.

Of the 101 institutional investors that purchased Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($4.80M), Gilead Sciences Inc. ($4.13M), BlackRock Inc. ($3.13M), Adage Capital Partners GP L.L.C. ($1.67M), Balyasny Asset Management L.P. ($980.87K), Propel Bio Management LLC ($666.67K), and Jacobs Levy Equity Management Inc. ($609.67K).

Institutional investors have bought a total of 17,452,320 shares in the last 24 months. This purchase volume represents approximately $157.02M in transactions.

Of the 15 institutional investors that sold Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Kera Capital Partners Inc. ($313.84K), Bain Capital Life Sciences Investors LLC ($258.37K), Peapod Lane Capital LLC ($212.94K), TD Asset Management Inc ($87.40K), Squarepoint Ops LLC ($64.11K), JPMorgan Chase & Co. ($42.36K), and ADAR1 Capital Management LLC ($35K).

Institutional investors have sold a total of 1,155,784 shares in the last 24 months. This volume of shares sold represents approximately $9.83M in transactions.


Related Companies

Institutional ownership data for NASDAQ:KYTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel